Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-Jκ in B lymphocytes

Virology

Volumn 226, Issue 2, 1996, Pages 346-353

  Krauer, Kenia G ^a   Kienzle, Norbert ^a   Young, David B ^a   Sculley, Tom B ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; DNA VIRUS; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MUTATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030589480     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0662     Document Type: Article

References (35)

1. Amakawa, R., Jng, W., Ozawa, K., Matsunami, N., Hamaguchi, Y., Matsuda, F., Kawaichi, M., and Tonjo, T. (1993). Human Jκ recombination signal binding protein gene (IGKJRB): Comparison with its mouse homologue. Genomics 17, 306-315.
2. Ben Bassat, H., Goldblum, N., Mitrani, S., Goldblum, T., Yoffey, J. M., Cohen, M. M., Bentwich, Z., Ramot, B., Klein, E., and Klein, G. (1977). Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int. J. Cancer 19, 27-33.
3. Chien, C-T., Bartel, P. L., Sternglanz, R., and Fields, S. (1991). The two-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. USA 88, 9578-9582.
4. Collins, S. J., Gallo, R. C., and Gallagher, R. E. (1977). Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 270, 347-349.
5. Dou, S., Zeng, X., Cortes, P., Erdjument-Bromage, H., Tempst, P., Honjo, T., and Vales, L. D. (1994). The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Mol. Cell. Biol. 14, 3310-3319.
6. Gregory, C. D., Rowe, M., and Rickinson, A. B. (1990). Different Epstein-Barr virus (EBV) B cell interactions in phenotypically distinct clones of a Burkitt lymphoma cell line. J Gen. Virol. 71, 1481-1495.
7. Hammerschmidt, W., Sugden, B., and Baichwal, V. R. (1989). The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 63, 2469-2475.
8. Harlow, E., and Lane, D. (1988). "Antibodies, A Laboratory Manual." Cold Spring Harbor Laboratory, Cold Springs Harbor, NY.
9. Hsieh, J. J.-D., and Hayward, S. D. (1995). Masking of the CBF1/RBPjκ transcriptional repression domain by Epstein-Barr virus EBNA-2. Science 268, 560-263.
10. Johannsen, E., Miller, C. L., Grossman, S. R., and Kieff, E. (1996). EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJκ in Epstein-Barr virus-transformed B lymphocytes. J. Virol. 70, 4179-4183.
11. Kallin, B., Dillner, J., Ernberg, I., Ehlin-Henriksson, B., Rosen, A., Henle, W., Henle, G., and Klein, G. (1986). Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proc. Natl. Acad. Sci. USA 83, 1499-1503.
12. Kawaichi, M., Oka, C., Shibayama, S., Koromilas, A. E., Matsunami, N., Hamaguchi, Y., and Honjo, T. (1992). Genomic organization of mouse Jκ recombination signal binding protein (RBP-Jκ) gene. J. Biol. Chem. 267, 4016-4022.
13. Kieff, E., and Liebowitz, D. (1990). Epstein-Barr virus and its replication. In "Virology," 2nd ed. (B. N. Fields, D. M. Knipe, R. M., Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman, Eds.), pp. 1889-1920. Raven Press, New York.
14. Kienzle, N., Young, D., Silins, S. L., and Sculley, T. B. (1996). Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family. Virology 224, in press.
15. Kienzle, N., Young, D., Zehntner, S., Bushell, G., and Sculley, T. B. (1996b). DNasel treatment is a prerequisite for the amplification of cDNA from episomal-based genes. BioTechniques 20, 612-616.
16. Klein, G., Lindahl, T., Jondal, M., Leibold, W., Menzes, J., Nilsson, K., and Sundstrom, C. (1974). Continuous lymphoid cell line with characteristics of B cells (bone marrow-derived) lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc. Natl. Acad. Sci. USA 71, 3283-3286.
17. Le Roux, A., Kerdilles, B., Walls, D., Dedieu, J-F., and Perricuadet, M. (1994). The Epstein-Barr virus-determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205, 596-602.
18. Ling, P. D., Hsieh, J. J-D., Ruf, I. K., Rawlins, D. R., and Hayward, D. (1994). EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J. Virol. 68, 5375-5383.
19. Margolskee, R. F., Kavathas, P., and Berg, P. (1988). Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells. Mol. Cell Biol. 8, 2837-2847.
20. Marshall, D., and Sample, C. (1995). Epstein-Barr virus nuclear antigen EBNA-3C is a transcriptional regulator. J. Virol. 69, 3624-3630.
21. Miller, J. H. (1972). "Experiments in Molecular Genetics." Cold Spring Harbor Laboratory, Cold Springs Harbor, NY.
22. Rickinson, A., Young, L., and Rowe, M. (1987). Influence of the Epstein-Barr virus nuclear antigen EBNA-2 on the growth phenotype of virus-transformed B cells. J. Virol. 61, 1310-1317.
23. Robertson, E. S., Grossman, S., Johannsen, E., Miller, C., Lin, J., Tomkinson, B., and Kieff, E. (1995). Epstein-Barr virus nuclear protein modulates transcription through interaction with the sequence-specific DNA-binding protein RBP-Jκ. J. Virol. 69, 3108-3116.
24. Robertson, E. S., Lin, J., and Kieff, E. (1996). The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJκ. J. Virol. 70, 3068-3074.
25. Rowe, M., Young, L., Cadwallader, K., Petti, L., Kieff, E., and Rickinson, A. (1989). Distinction between Epstein-Barr virus type A (EBNA-2A) and type B (EBNA-2B) isolates extends to the EBNA-3 family of nuclear proteins. J. Virol. 63, 1031-1039.
26. Sakai, T., Furukawa, T., Iwanari, H., Oka, C., Nakano, T., Kawaichi, M., and Honjo, T. (1995). Loss of immunostaining of the RBP-Jκ transcription factor upon F9 cell differentiation induced by retinoic acid. J. Biochem. 118, 621-628.
27. Sample, C., and Parker, B. (1994). Biochemical characterisation of Epstein-Barr virus nuclear antigen 3A and 3C proteins. Virology 205, 534-539.
28. Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E., Rickinson, A., and Kieff, E. (1990). Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64, 4084-4092.
29. Schweisguth, F., and Posakony, J. W. (1992). Suppressor of hairless, the Drosophila homolog of the mouse recombination signal-binding protein gene, controls sensory organ cell fates. Cell 69, 1199-1212.
30. Silins, S. L., and Sculley, T. B. (1994). Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4. Virology 202, 16-24.
31. Tomkinson, B., and Kieff, E. (1992). Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J. Virol. 66, 2893-2903.
32. Tomkinson, B., Robertson, E., and Kieff, E. (1993). Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth and transformation. J. Virol. 67, 2014-2025.
33. Wang, F., Gregory, C. D., Rowe, M., Rickinson, A. B., Wang, D., Birkenbach, M., Kikutani, H., Kishimoto, T., and Kieff, E. (1987). Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl. Acad. Sci. USA 84, 3452-3456.
34. Young, D. B., Krauer, K. G., and Sculley, T. B. Both A type and B type Epstein-Barr nuclear antigen 6 interacts with RBP-2N. Submitted.
35. Zhao, B., Marshall, D. R., and Sample, C. E. (1996). A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jκ. J. Virol. 70, 4228-4236.